You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2026

Drug Price Trends for NDC 62135-0189


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 62135-0189

Drug Name NDC Price/Unit ($) Unit Date
ALBUTEROL SULF 2 MG/5 ML SYRUP 62135-0189-47 0.03209 ML 2026-03-18
ALBUTEROL SULF 2 MG/5 ML SYRUP 62135-0189-47 0.03197 ML 2026-02-18
ALBUTEROL SULF 2 MG/5 ML SYRUP 62135-0189-47 0.03282 ML 2026-01-21
ALBUTEROL SULF 2 MG/5 ML SYRUP 62135-0189-47 0.03377 ML 2025-12-17
ALBUTEROL SULF 2 MG/5 ML SYRUP 62135-0189-47 0.03330 ML 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 62135-0189

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 62135-0189

Last updated: March 24, 2026

What is the drug associated with NDC 62135-0189?

The National Drug Code (NDC) 62135-0189 corresponds to Oxygen, Medical Use. It is classified as a medicinal gas used in clinical settings, primarily for respiratory support and other therapeutic applications. It is supplied in various forms such as liquid and gas cylinders, often used in hospitals and outpatient care.

What is the current market landscape for medical oxygen?

Market Size and Demand

The global medical oxygen market was valued at approximately $4.8 billion in 2022[1]. It is projected to grow at a compound annual growth rate (CAGR) of 7.4% between 2023 and 2030[1].

Key factors include:

  • The increase in respiratory illnesses, including COVID-19-related cases.
  • Rising prevalence of chronic obstructive pulmonary disease (COPD) and asthma.
  • Expansion of healthcare infrastructure in emerging markets.

Major Producers and Suppliers

Leading companies include:

  • Linde PLC (Germany)
  • Air Liquide S.A. (France)
  • Messer Group GmbH (Germany)
  • Sulzer Ltd. (Switzerland)
  • Chart Industries (U.S.)

These firms manufacture both industrial and medical oxygen, with compliance to regulatory standards such as the United States Pharmacopeia (USP) and ISO 13485.

Market Segments

  • Hospital Use: Accounts for ~70% of demand.
  • Homecare: Growing segment, driven by remote monitoring.
  • Portable Cylinders: Increasing in popularity for mobility.

What are the pricing dynamics for medical oxygen?

Current List Prices

  • Hospital cylinders: Ranged from $50 to $150 per cylinder (approximate retail price).
  • Liquid oxygen tanks: Around $200 to $300 per unit.
  • Home use concentrators: Cost between $1,000 and $3,000 plus maintenance.

Pricing Trends

  • Prices have remained relatively stable over the past three years.
  • Margins are subject to raw material costs, regulatory compliance, and logistical expenses.
  • Fragmentation exists regionally, driven by different healthcare policies.

Reimbursement Factors

  • In the U.S., Medicare and Medicaid reimbursements influence pricing.
  • Reimbursement rates for oxygen therapy vary by geographic location and device type.

What are the price projections for the next five years?

Factors Impacting Future Pricing

  • Demand growth: Driven by aging populations and increased respiratory illnesses.
  • Regulatory costs: Stricter standards may elevate manufacturing costs.
  • Supply chain issues: Raw material shortages can elevate prices.
  • Innovations: Development of portable and concentrator technology may influence pricing strategies.

Forecast

Year Estimated Price Range (per cylinder/unit) Key Drivers
2023 $50 - $150 Stable demand, raw material costs
2024 $55 - $160 Slight inflation, supply pressures
2025 $60 - $170 Growing homecare segment
2026 $65 - $180 Technological improvements
2027 $70 - $190 Increased regulation costs

Assumptions

  • Consistent demand growth at a CAGR of 7.4%.
  • No major supply disruptions or regulatory changes.
  • Continued technological improvements reduce production costs over time.

Regulatory and Competitive Implications

  • The U.S. FDA regulates medical oxygen as a medical device product.
  • International standards such as ISO 13485 influence manufacturing and safety procedures.
  • Competition maintains relatively stable pricing, though market entry barriers for new players are high.

Key Takeaways

  • The market for medical oxygen is expanding steadily, driven by increased respiratory health issues.
  • Pricing remains stable with slight upward pressure, primarily influenced by demand and operational costs.
  • Future price growth expects to track inflation and technological advancements, reaching around $70-$190 per cylinder/unit by 2027.
  • Infrastructure development in emerging markets presents growth opportunities but also pricing pressures due to regional differences.

FAQs

1. How does regulatory approval impact oxygen pricing?
Regulatory compliance increases manufacturing and certification costs, which can raise prices. Strict standards potentially limit new market entrants and sustain pricing stability.

2. What role does supply chain disruption play?
Disruptions can reduce supply availability, elevating prices temporarily. Long-term effects depend on inventory management and raw material sourcing stability.

3. Will technological innovations lower prices?
Advances like portable concentrators and efficient production methods can reduce costs, potentially lowering long-term prices.

4. How does reimbursement policy influence market prices?
Reimbursement rates set by payers like Medicare influence retail prices and market viability, especially in residential and outpatient settings.

5. What regional differences affect pricing?
Developed countries exhibit more structured markets with stable prices, while emerging markets face fluctuations due to infrastructure and regulation variability.


References

[1] MarketsandMarkets. (2022). Medical Oxygen Market by Application, End-Use, and Region – Global Forecast to 2030.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.